Gadeta's Seed VC Round

Gadeta raised a round of funding on , . Investors include Medicxi Ventures.

Gadeta has developed a technology platform based on combinatorial T Cell receptor exchange (CTE) to create optimized gamma delta (γδ) T-cell receptors (TCRs) with an enhanced anti-cancer reactivity.…

Articles about Gadeta's Seed VC Round: